EP1855600A2 - Dispositif et procedes de decoupe non chirurgicale d'anevrismes - Google Patents

Dispositif et procedes de decoupe non chirurgicale d'anevrismes

Info

Publication number
EP1855600A2
EP1855600A2 EP06727243A EP06727243A EP1855600A2 EP 1855600 A2 EP1855600 A2 EP 1855600A2 EP 06727243 A EP06727243 A EP 06727243A EP 06727243 A EP06727243 A EP 06727243A EP 1855600 A2 EP1855600 A2 EP 1855600A2
Authority
EP
European Patent Office
Prior art keywords
aneurysm
guiding
guiding needle
lumen
wires
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP06727243A
Other languages
German (de)
English (en)
Other versions
EP1855600B1 (fr
EP1855600A4 (fr
Inventor
Jacob Richter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zuli Holdings Ltd
Original Assignee
Zuli Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zuli Holdings Ltd filed Critical Zuli Holdings Ltd
Publication of EP1855600A2 publication Critical patent/EP1855600A2/fr
Publication of EP1855600A4 publication Critical patent/EP1855600A4/fr
Application granted granted Critical
Publication of EP1855600B1 publication Critical patent/EP1855600B1/fr
Not-in-force legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12009—Implements for ligaturing other than by clamps or clips, e.g. using a loop with a slip knot
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12009—Implements for ligaturing other than by clamps or clips, e.g. using a loop with a slip knot
    • A61B17/12013—Implements for ligaturing other than by clamps or clips, e.g. using a loop with a slip knot for use in minimally invasive surgery, e.g. endoscopic surgery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/122—Clamps or clips, e.g. for the umbilical cord
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/06—Needles ; Sutures; Needle-suture combinations; Holders or packages for needles or suture materials
    • A61B17/06166—Sutures
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00831—Material properties
    • A61B2017/00867—Material properties shape memory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/06—Needles ; Sutures; Needle-suture combinations; Holders or packages for needles or suture materials
    • A61B2017/06052—Needle-suture combinations in which a suture is extending inside a hollow tubular needle, e.g. over the entire length of the needle

Definitions

  • the present invention relates to a device for the non-surgical clipping of aneurysms.
  • the invention also encompasses methods of use to treat aneurysms, including intracranial aneurysms.
  • An aneurysm is a phenomenon in which the wall of a blood vessel is abnormally dilated due to weakening of the vessel wall.
  • Common areas where aneurysms occur and cause potential medical conditions include the cerebral arteries, coronary arteries, the carotid arteries, the thoracic aorta, and the abdominal aorta.
  • Aneurysms pose a danger because the blood pressure within the aneurysm could cause the vessel to rupture.
  • Vessel rupture in turn, often causes dramatic negative health consequences, such as a stroke in the case of a cerebral vessel rupture.
  • Morbidity related to the conventional surgery includes myocardial infarction, renal failure, impotence, paralysis, and other conditions. Even with successful surgery, recovery takes several weeks and often requires a lengthy hospital stay. The location of an aneurysm may in many cases be buried in the brain and inaccessible form the outside and thus present no surgical option. In such cases, the aneurysm may only be accessible endovascularly.
  • Such techniques typically involve attempting to form a mass within the sac of the aneurysm.
  • a microcatheter is used to access the aneurysm.
  • the distal tip of the micro catheter is placed within the sac of the aneurysm, and the microcatheter is used to inject embolic material into the sac of the aneurysm.
  • the embolic material includes, for example, detachable coils (e.g., Guglielmi Detachable Coils) or an embolic agent, such as a liquid polymer.
  • detachable coils e.g., Guglielmi Detachable Coils
  • an embolic agent such as a liquid polymer.
  • aneurysm having a wide connection to the blood vessel (e.g., wide neck aneurysms). Wide neck aneurysms have the additional risk that the occluded material will break free of the aneurysm and enter the parent blood vessel.
  • Treatment of an aneurysm by Detachable Coils is oftentimes long and involves many coils, the result is unpredictable and may not be successful at excluding blood flow from the aneurysm.
  • the present invention relates to a device for the non-surgical clipping of aneurysms in a patient in need thereof.
  • the device of the present invention comprises a guiding catheter encompassing a guiding needle.
  • the guiding needle is a hollow tube with a needle tip at its distal end.
  • a wire comprising a shape memory alloy is encompassed by the guiding needle and the guiding catheter.
  • the diameters of each member are of a size such that each of the members can easily slide through the member that encompasses it.
  • the aneurysm is clipped by positioning a wire comprising a shape memory alloy on each side of the neck of the aneurysm (using the guiding catheter and guiding needle) and causing the wires to twist around each other in the memorized shape, i.e., that had been set by a high heat treatment, for example.
  • the aneurysm is substantially isolated from the lumen of the vessel and has a substantial reduction in blood flow and pressure. The reduced blood flow and pressure may cause thrombosis of the aneurysm and therefore reduces the risk of aneurysm rupture.
  • any aneurysm can be treated according to the methods of the invention.
  • the aneurysm is an intracranial aneurysm.
  • FIG. 1 is a schematic view of a guiding catheter 1 encompassing a guiding needle 2 which in turn encompasses a wire comprising a shape memory alloy 3.
  • the guiding needle 2 has a sharp tip on its distal end.
  • FIG. 2 is a schematic view of a cross section of a blood vessel with a lumen 4 and an aneurysm 5.
  • the guiding catheter 1 is positioned in the lumen 4 proximal to the aneurysm 5.
  • the guiding needle 2 is shown leaving the vessel lumen 4 through a first perforation 6 in the vessel wall immediately proximal to the aneurysm 5, tracking along a first side of the aneurysm 5, and re-entering the vessel lumen 4 through a second perforation 7 in the vessel wall distal to the aneurysm 5.
  • FIG. 3 is a view of a cross section of a blood vessel with a lumen 4 and an aneurysm 5.
  • a first wire comprising a shape memory alloy 3 is shown being deployed from the guiding needle 2.
  • the guiding catheter 1 remains positioned in the lumen 4 proximal to the aneurysm 5.
  • FIG. 4 is a view of a cross section of a blood vessel with a lumen 4 and an aneurysm 5.
  • the guiding needle has been retracted back into the guiding catheter 1 though the first 6 and second 7 perforations leaving the first wire comprising a shape memory alloy 3 positioned around the first side of the aneurysm 5.
  • FIG 5. is a view of a cross section of a blood vessel with a lumen 4 and an aneurysm 5.
  • the guiding needle 2 is shown leaving the vessel lumen 4 through a third perforation 8 in the vessel wall immediately proximal to the aneurysm 5, tracking along a second side of the aneurysm 5, and re-entering the vessel lumen 4 through a fourth perforation 9 in the vessel wall distal to the aneurysm 5.
  • a second wire comprising a shape memory alloy 10 is shown being deployed from the guiding needle 2.
  • the guiding catheter 1 remains positioned in the lumen 4 proximal to the aneurysm 5.
  • the first wire comprising a shape memory alloy 3 remains positioned around the first side of the aneurysm 5.
  • FIG. 6 is a view of a cross section of a blood vessel with a lumen 4 and an aneurysm 5.
  • the guiding needle has been retracted back into the guiding catheter 1 though the third 8 and fourth 9 perforations leaving the second wire comprising a shape memory alloy 10 positioned around the second side of the aneurysm 5.
  • the first wire 3 and the second wire 10 are on either side of the neck of the aneurysm 5.
  • FIG. 7 is a view of a cross section of a blood vessel with a lumen 4 and an aneurysm 5.
  • the first wire 3 and second wire 10 are twisted around each other.
  • the neck of the aneurysm 5 has been substantially clipped.
  • FIG. 1 illustrates a device for the use in the non-surgical clipping of an aneurysm.
  • the guiding catheter 1 encompasses a guiding needle 2 which encompasses a wire comprising a shape memory alloy 3.
  • the guiding catheter 1 is essentially any catheter known in the art capable of getting to the affected area (i.e., the lumen of a blood vessel or artery proximal to an aneurysm) and allowing the passage of a guiding needle.
  • the guiding needle 2 is a hollow tube with a needle tip at its distal end.
  • the guiding needle can perforate the wall of the blood vessel thus allowing the properly shaped guiding needle to exit and re-enter the vessel lumen.
  • the guiding needle can be made of any known material that can pass through the guiding catheter, and is shaped with the appropriate curvature such that it can exit and re-enter the vessel lumen, and that can deliver the wire comprising a shape memory alloy. Such materials include, but are not limited to, metal or a reinforced polymer material.
  • the wire comprising a shape memory alloy 3 is made from such metal alloy that allows it to be straight during deployment and then assume a pre-set twisted form that was thermo mechanically predetermined, this transformation being triggered by a temperature step.
  • the temperature step may be affected by changing the temperature of the environment around the wire, e.g., by hot fluid or body heat, or by passing current through the wire generating resistive heat.
  • any shape memory alloy can be used to make the wire comprising a shape memory alloy.
  • the shape memory alloy used is NiTi (e.g., NiTinol), CuZnAl, CuAlNi, or a mixture thereof (see, e.g., Shape Memory Materials, edited by Otsuka and Wayman, Cambridge University Press; October 1999 and Shape Memory Alloys, edited by Youyi and Otsuka, International Academic Publishers, June 1998).
  • FIG. 2 illustrates the device whose tip is shown in FIG. 1.
  • the devise is positioned in the lumen 4 of a blood vessel proximal to an aneurysm 5.
  • the guiding catheter can be passed through the body lumen to the affected area by any method known in the art.
  • the affected area is identified by diagnostic methods known in the art, e.g., MRI, Angiogram, or the like.
  • the location of the catheter can be monitored by any method known in the art.
  • the progress of the catheter through the lumen is monitored by a device that detects radiopacity of the catheter device such as angiographic equipment in X-ray. Increased radiopacity can be provided to the catheter by manufacturing (all or a part of) or coating (all or a part of) the catheter with one or more radiopaque materials.
  • the method of using the device to treat an aneurysm begins with the guiding needle 2 being deployed from the guiding catheter 1.
  • the guiding needle 2 perforates the vessel wall (first perforation 6).
  • the guiding needle is then passed through the first perforation 6 and leaves the vessel lumen 4 immediately proximal to the aneurysm 5.
  • the guiding needle is then tracked along the exterior vessel wall until it passes the aneurysm 5 on a first side of the aneurysm.
  • the guiding needle 2 perforates the vessel wall (second perforation 7) and passes through the perforation to re-enter the vessel lumen 4 immediately distal to the aneurysm 5.
  • the position of the guiding needle can be monitored by any method known in the art.
  • FIG. 3 illustrates the next step in the method of the invention to treat an aneurysm.
  • a first wire comprising a shape memory alloy 3 is fed through and deployed from the guiding needle 2.
  • FIG. 4 illustrates the next step in the method of the invention to treat an aneurysm.
  • the guiding needle is retracted back into the guiding catheter 1 though the first 6 and second 7 perforations leaving the first wire comprising a shape memory alloy 3 positioned around the first side of the aneurysm 5.
  • FIG 5. illustrates the next step in the method of the invention to treat an aneurysm.
  • the guiding needle 2 is deployed from the guiding catheter 1 for a second time.
  • the guiding needle 2 perforates the vessel wall (third perforation 8).
  • the guiding needle is then passed through the third perforation 8 and leaves the vessel lumen 4 immediately proximal to the aneurysm 5.
  • the guiding needle is then tracked along the exterior vessel wall until it passes the aneurysm 5 on a second side of the aneurysm (the side of the aneurysm opposite the first wire comprising a shape memory alloy).
  • the guiding needle 2 perforates the vessel wall (fourth perforation 9) and passes through the perforation to re-enter the vessel lumen 4 immediately distal to the aneurysm 5.
  • a second wire comprising a shape memory alloy 10 is fed through and deployed from the guiding needle 2.
  • Perforations 1 and 3 may be separate perforations or they may overlap.
  • Perforations 2 and 4 may be separate perforations or they may overlap.
  • FIG. 6 illustrates the next step in the method of the invention to treat an aneurysm.
  • the guiding needle is retracted back into the guiding catheter 1 through the third 8 and fourth 9 perforations leaving the second wire comprising a shape memory alloy 10 positioned around the second side of the aneurysm 5 (i.e., opposite that of the first wire).
  • the first wire 3 and the second wire 10 are now on either side of the neck of the aneurysm 5.
  • the first and second wires comprising a shape memory alloy have been pre-conditioned such that when heated they will revert to a mutually twisted configuration. This is accomplished by the first and second wires twisting around each other after heating them due to the pre-set twisted shape of the wires.
  • FIG. 7 illustrates the last step in the method of the invention to treat an aneurysm.
  • the guiding catheter and the guiding needle are retracted through the vessel and removed from the patient leaving the twisted first 3 and second 10 wires.
  • the first wire 3 and second wire 10 are twisted around each other by application of moderate heat.
  • the neck of the aneurysm is pressed close by the twisted wires.
  • the amount of heat necessary to cause the shape reversion of the wires will vary depending on, e.g., the type of shape memory alloy used, the thickness of the wire, etc.
  • the heat necessary to cause shape reversion is body heat.
  • the heat necessary to cause shape reversion is higher than body heat.
  • any means of applying the moderate heat necessary to cause the shape reversion of the first and second wires can be used.
  • a mild electric current may be passed through the wires to heat them.

Landscapes

  • Health & Medical Sciences (AREA)
  • Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Reproductive Health (AREA)
  • Medical Informatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Surgical Instruments (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
EP06727243A 2005-02-04 2006-02-01 Dispositif de traitement d'un anévrisme Not-in-force EP1855600B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65035205P 2005-02-04 2005-02-04
PCT/IB2006/000178 WO2006082493A2 (fr) 2005-02-04 2006-02-01 Dispositif et procedes de decoupe non chirurgicale d'anevrismes

Publications (3)

Publication Number Publication Date
EP1855600A2 true EP1855600A2 (fr) 2007-11-21
EP1855600A4 EP1855600A4 (fr) 2009-08-12
EP1855600B1 EP1855600B1 (fr) 2011-06-29

Family

ID=36777597

Family Applications (1)

Application Number Title Priority Date Filing Date
EP06727243A Not-in-force EP1855600B1 (fr) 2005-02-04 2006-02-01 Dispositif de traitement d'un anévrisme

Country Status (9)

Country Link
US (2) US7601160B2 (fr)
EP (1) EP1855600B1 (fr)
JP (1) JP4777364B2 (fr)
AT (1) ATE514384T1 (fr)
AU (1) AU2006211015B2 (fr)
CA (1) CA2595918C (fr)
ES (1) ES2368857T3 (fr)
IL (1) IL184938A (fr)
WO (1) WO2006082493A2 (fr)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8425549B2 (en) 2002-07-23 2013-04-23 Reverse Medical Corporation Systems and methods for removing obstructive matter from body lumens and treating vascular defects
US9675476B2 (en) 2004-05-25 2017-06-13 Covidien Lp Vascular stenting for aneurysms
AU2005247490B2 (en) 2004-05-25 2011-05-19 Covidien Lp Flexible vascular occluding device
SG175723A1 (en) 2004-05-25 2011-12-29 Tyco Healthcare Vascular stenting for aneurysms
US8152833B2 (en) 2006-02-22 2012-04-10 Tyco Healthcare Group Lp Embolic protection systems having radiopaque filter mesh
US8053068B2 (en) * 2007-03-29 2011-11-08 Kazak Composites, Incorporated Shape memory alloy composite material shock and vibration isolator devices
CN102014769B (zh) 2008-04-21 2012-12-12 纽福克斯神经医疗公司 编织球栓塞装置及输送系统
WO2009140437A1 (fr) 2008-05-13 2009-11-19 Nfocus Neuromedical, Inc. Systèmes de pose d'implant tressé
WO2010011694A1 (fr) 2008-07-22 2010-01-28 Micro Therapeutics, Inc. Dispositif de remodelage vasculaire
US8409269B2 (en) 2009-12-21 2013-04-02 Covidien Lp Procedures for vascular occlusion
CN102791205B (zh) 2009-11-09 2016-02-03 恩福克斯神经医学股份有限公司 栓塞装置
GB0919950D0 (en) * 2009-11-13 2009-12-30 Btg Int Ltd Clamp and applicator
CN102770091B (zh) 2010-01-28 2015-07-08 泰科保健集团有限合伙公司 脉管重塑装置
US9468442B2 (en) 2010-01-28 2016-10-18 Covidien Lp Vascular remodeling device
US9113927B2 (en) * 2010-01-29 2015-08-25 Covidien Lp Apparatus and methods of use for treating blood vessels
WO2012034135A1 (fr) 2010-09-10 2012-03-15 Maria Aboytes Dispositifs et méthodes utilisés pour le traitement d'anomalies vasculaires
US8998947B2 (en) 2010-09-10 2015-04-07 Medina Medical, Inc. Devices and methods for the treatment of vascular defects
US8915950B2 (en) 2010-12-06 2014-12-23 Covidien Lp Vascular remodeling device
CA2825774C (fr) 2011-02-11 2017-02-28 Frank P. Becking Dispositifs d'embolisation d'anevrisme a deploiement en deux etapes
WO2012134990A1 (fr) 2011-03-25 2012-10-04 Tyco Healthcare Group Lp Dispositif de remodelage vasculaire
CN103547222B (zh) 2011-05-11 2016-02-10 柯惠有限合伙公司 脉管重塑装置
US9060886B2 (en) 2011-09-29 2015-06-23 Covidien Lp Vascular remodeling device
US9072620B2 (en) 2011-11-04 2015-07-07 Covidien Lp Protuberant aneurysm bridging device deployment method
US9011480B2 (en) 2012-01-20 2015-04-21 Covidien Lp Aneurysm treatment coils
JP2013154089A (ja) 2012-01-31 2013-08-15 Terumo Corp 瘤治療デバイス及び瘤治療方法
US9452070B2 (en) 2012-10-31 2016-09-27 Covidien Lp Methods and systems for increasing a density of a region of a vascular device
US9314248B2 (en) 2012-11-06 2016-04-19 Covidien Lp Multi-pivot thrombectomy device
EP2919668A2 (fr) 2012-11-13 2015-09-23 Covidien LP Dispositifs d'occlusion
US9295571B2 (en) 2013-01-17 2016-03-29 Covidien Lp Methods and apparatus for luminal stenting
US9463105B2 (en) 2013-03-14 2016-10-11 Covidien Lp Methods and apparatus for luminal stenting
US10076336B2 (en) 2013-03-15 2018-09-18 Covidien Lp Delivery and detachment mechanisms for vascular implants
EP2967571B1 (fr) 2013-03-15 2022-08-31 Covidien LP Dispositif occlusif
WO2015073704A1 (fr) 2013-11-13 2015-05-21 Covidien Lp Fixation galvaniquement assistée de dispositifs médicaux à un thrombus
US9713475B2 (en) 2014-04-18 2017-07-25 Covidien Lp Embolic medical devices
US9814466B2 (en) 2014-08-08 2017-11-14 Covidien Lp Electrolytic and mechanical detachment for implant delivery systems
US10478194B2 (en) 2015-09-23 2019-11-19 Covidien Lp Occlusive devices
US10314593B2 (en) 2015-09-23 2019-06-11 Covidien Lp Occlusive devices
DE102015121374B4 (de) 2015-12-08 2021-03-18 Otto-Von-Guericke-Universität Magdeburg Implantatsystem aufweisend eine Zuführeinheit und einen Clip zum Verschluss röhrenförmiger anatomischer Strukturen
EP3432826A1 (fr) 2016-03-24 2019-01-30 Covidien LP Constructions à paroi mince pour déviation d'écoulement vasculaire
US10828037B2 (en) 2016-06-27 2020-11-10 Covidien Lp Electrolytic detachment with fluid electrical connection
US10828039B2 (en) 2016-06-27 2020-11-10 Covidien Lp Electrolytic detachment for implantable devices
US11051822B2 (en) 2016-06-28 2021-07-06 Covidien Lp Implant detachment with thermal activation
US10478195B2 (en) 2016-08-04 2019-11-19 Covidien Lp Devices, systems, and methods for the treatment of vascular defects
US10576099B2 (en) 2016-10-21 2020-03-03 Covidien Lp Injectable scaffold for treatment of intracranial aneurysms and related technology
CA3044538A1 (fr) * 2016-11-30 2018-06-07 The Regents Of The University Of California Fabrication de micro-aiguilles et implantation de dispositif
US10675036B2 (en) 2017-08-22 2020-06-09 Covidien Lp Devices, systems, and methods for the treatment of vascular defects
US11065136B2 (en) 2018-02-08 2021-07-20 Covidien Lp Vascular expandable devices
US11065009B2 (en) 2018-02-08 2021-07-20 Covidien Lp Vascular expandable devices
US10905432B2 (en) 2018-08-22 2021-02-02 Covidien Lp Aneurysm treatment coils and associated systems and methods of use
US10912569B2 (en) 2018-08-22 2021-02-09 Covidien Lp Aneurysm treatment coils and associated systems and methods of use
EP3897409A2 (fr) 2018-12-17 2021-10-27 Covidien LP Dispositifs, systèmes et méthodes pour le traitement d'anomalies vasculaires
WO2021092618A1 (fr) 2019-11-04 2021-05-14 Covidien Lp Dispositifs, systèmes et procédés pour le traitement d'anévrismes intracrâniens
US11931041B2 (en) 2020-05-12 2024-03-19 Covidien Lp Devices, systems, and methods for the treatment of vascular defects

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6071292A (en) * 1997-06-28 2000-06-06 Transvascular, Inc. Transluminal methods and devices for closing, forming attachments to, and/or forming anastomotic junctions in, luminal anatomical structures
US20020022837A1 (en) * 2000-06-19 2002-02-21 Mazzocchi Rudy A. System and method of minimally-invasive exovascular aneurysm treatment
WO2002039906A2 (fr) * 2000-11-20 2002-05-23 Avantec Vascular Corporation Methode et dispositif de traitement d'un site tissulaire vulnerable
US20040002718A1 (en) * 2002-04-17 2004-01-01 Hugh Trout Apparatus and method for placement of surgical fasteners
WO2004014435A2 (fr) * 2002-08-08 2004-02-19 Interrad Medical, Inc. Systeme d'agrafes de ligature chirurgicales non invasif et son procede d'utilisation
US20040210240A1 (en) * 2003-04-21 2004-10-21 Sean Saint Method and repair device for treating mitral valve insufficiency

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3532565B2 (ja) 1991-12-31 2004-05-31 ミネソタ マイニング アンド マニュファクチャリング カンパニー 再剥離型低溶融粘度アクリル系感圧接着剤
JPH10155800A (ja) * 1996-11-26 1998-06-16 Olympus Optical Co Ltd 緊縛用ループ及び結紮装置
US6511468B1 (en) * 1997-10-17 2003-01-28 Micro Therapeutics, Inc. Device and method for controlling injection of liquid embolic composition
US6063111A (en) * 1998-03-31 2000-05-16 Cordis Corporation Stent aneurysm treatment system and method
CA2334223C (fr) * 1998-06-04 2008-11-18 New York University Dispositifs endovasculaires a couche mince et procedes permettant de traiter et de prevenir un accident cerebrovasculaire
WO2003017259A1 (fr) * 2001-08-15 2003-02-27 Hitachi Maxell, Ltd. Bande magnetique et cartouche de bande magnetique
US20040260384A1 (en) * 2003-06-17 2004-12-23 Medtronic Ave Superelastic coiled stent

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6071292A (en) * 1997-06-28 2000-06-06 Transvascular, Inc. Transluminal methods and devices for closing, forming attachments to, and/or forming anastomotic junctions in, luminal anatomical structures
US20020022837A1 (en) * 2000-06-19 2002-02-21 Mazzocchi Rudy A. System and method of minimally-invasive exovascular aneurysm treatment
WO2002039906A2 (fr) * 2000-11-20 2002-05-23 Avantec Vascular Corporation Methode et dispositif de traitement d'un site tissulaire vulnerable
US20040002718A1 (en) * 2002-04-17 2004-01-01 Hugh Trout Apparatus and method for placement of surgical fasteners
WO2004014435A2 (fr) * 2002-08-08 2004-02-19 Interrad Medical, Inc. Systeme d'agrafes de ligature chirurgicales non invasif et son procede d'utilisation
US20040210240A1 (en) * 2003-04-21 2004-10-21 Sean Saint Method and repair device for treating mitral valve insufficiency

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2006082493A2 *

Also Published As

Publication number Publication date
EP1855600B1 (fr) 2011-06-29
IL184938A0 (en) 2008-01-20
US8202280B2 (en) 2012-06-19
CA2595918C (fr) 2010-09-28
AU2006211015B2 (en) 2010-12-16
ATE514384T1 (de) 2011-07-15
CA2595918A1 (fr) 2006-08-10
ES2368857T3 (es) 2011-11-23
WO2006082493A3 (fr) 2008-11-27
AU2006211015A1 (en) 2006-08-10
US20060178679A1 (en) 2006-08-10
US20090299383A1 (en) 2009-12-03
JP2008532575A (ja) 2008-08-21
IL184938A (en) 2013-07-31
US7601160B2 (en) 2009-10-13
EP1855600A4 (fr) 2009-08-12
WO2006082493A2 (fr) 2006-08-10
JP4777364B2 (ja) 2011-09-21

Similar Documents

Publication Publication Date Title
US7601160B2 (en) Device and methods for non-surgical clipping of aneurysms
US11033277B2 (en) Systems and methods for treating aneurysms
JP6317678B2 (ja) 医学的治療を支援するための装置及び方法
US9788840B2 (en) Intracorporeal occlusive device and method
AU709076B2 (en) Aneurysm closure device assembly
US8545530B2 (en) Implantable aneurysm closure systems and methods
CN109984800A (zh) 动脉瘤装置及递送系统
US20190343534A1 (en) Self-adapting floating diameter embolic coil and delivery system
US20100010533A1 (en) Variable strength embolization coil
JP2019524342A (ja) 血管内分流装置
JP6513859B2 (ja) マーカーを有する編組拡張リング
JP6100454B2 (ja) 生体管腔閉塞装置
KR20100049560A (ko) 관절 세그먼트에 의해 분리되는 반복된 확장 체적 세그먼트를 갖는 편조 폐색 장치
MX2010013476A (es) Dispositivo medico de multiples capas para el tratamiento de un sitio objetivo y metodo asociado.
CA2720641A1 (fr) Systeme de microcatheter a utilites multiples et procede d'utilisation
WO1999063896A2 (fr) Ensemble a dispositif de fermeture d'anevrisme
US20120172913A1 (en) Delivery of an embolization coil with an attacher
US10136897B2 (en) Expandable vaso-occlusive devices having shape memory and methods of using the same
KR20130118668A (ko) 혈관 폐쇄용 장치

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20070817

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK YU

DAX Request for extension of the european patent (deleted)
R17D Deferred search report published (corrected)

Effective date: 20081127

RIC1 Information provided on ipc code assigned before grant

Ipc: A61B 17/10 20060101AFI20090120BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20090710

RTI1 Title (correction)

Free format text: A DEVICE FOR THE TREATMENT OF AN ANEURYSM

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602006022787

Country of ref document: DE

Effective date: 20110825

REG Reference to a national code

Ref country code: SE

Ref legal event code: TRGR

REG Reference to a national code

Ref country code: CH

Ref legal event code: NV

Representative=s name: P&TS SA

REG Reference to a national code

Ref country code: NL

Ref legal event code: T3

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20110629

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2368857

Country of ref document: ES

Kind code of ref document: T3

Effective date: 20111123

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20110629

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20110930

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20110629

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20110629

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20110629

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20111029

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20111031

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20110629

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20110629

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20110629

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20110629

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20110629

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20110629

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20120330

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20110629

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602006022787

Country of ref document: DE

Effective date: 20120330

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20120229

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20110929

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20110629

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20120201

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20060201

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 11

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 12

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 13

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 20190226

Year of fee payment: 14

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IT

Payment date: 20190222

Year of fee payment: 14

Ref country code: IE

Payment date: 20190227

Year of fee payment: 14

Ref country code: GB

Payment date: 20190227

Year of fee payment: 14

Ref country code: ES

Payment date: 20190301

Year of fee payment: 14

Ref country code: DE

Payment date: 20190227

Year of fee payment: 14

Ref country code: CH

Payment date: 20190304

Year of fee payment: 14

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20190225

Year of fee payment: 14

Ref country code: SE

Payment date: 20190227

Year of fee payment: 14

Ref country code: BE

Payment date: 20190227

Year of fee payment: 14

REG Reference to a national code

Ref country code: DE

Ref legal event code: R119

Ref document number: 602006022787

Country of ref document: DE

REG Reference to a national code

Ref country code: SE

Ref legal event code: EUG

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

REG Reference to a national code

Ref country code: NL

Ref legal event code: MM

Effective date: 20200301

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20200201

REG Reference to a national code

Ref country code: BE

Ref legal event code: MM

Effective date: 20200229

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200202

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200229

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200229

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200301

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200901

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200229

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200201

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200201

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200229

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200202

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200201